{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T14:46:22Z","timestamp":1781966782570,"version":"3.54.5"},"reference-count":73,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Global Qualitative Nursing Research"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Healthcare providers employ various strategies to ensure continuous care for patients taking pre-exposure prophylaxis (PrEP) for HIV prevention. However, sustained engagement in care remains challenging, especially among populations at a higher risk of acquiring HIV, such as individuals who engage in high-risk alcohol use or have alcohol dependence. Understanding the provider-level factors\u2014markers of quality care\u2014that positively influence patient engagement remains underexplored. Through a descriptive qualitative approach and thematic analysis of 38 interviews with 14 participants who use PrEP and who screened positive for hazardous or harmful alcohol consumption (AUDIT scores &gt;7), six major themes were constructed that characterize PrEP quality care: (1) Access to Care and Continuity of Treatment, (2) Positive Patient-Provider Relationships, (3) Educational Engagement, (4) Psychosocial Support and Motivation, (5) Financial Accessibility, and (6) Peer Support. Overall, quality care in the context of PrEP is multifaceted, encompassing efficient service provision, positive patient-provider interactions, accessible and well-defined health education, psychosocial reinforcement, affordability, and peer-based support systems. These findings underscore the need for holistic approaches to PrEP care that address logistical, relational, educational, and financial factors to enhance patient experiences and outcomes.<\/jats:p>","DOI":"10.1177\/23333936261429417","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:32:12Z","timestamp":1774006332000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Markers of Quality Care in PrEP Services: Qualitatively Exploring Dimensions of Support Among Persons Who Engage in High-Risk Alcohol Use"],"prefix":"10.1177","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9338-2230","authenticated-orcid":false,"given":"Nqobile","family":"Nzama","sequence":"first","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley M.","family":"Harris","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake D.","family":"Skidmore","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juma S.","family":"Mwenda","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelani C.","family":"Kerr","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin T.","family":"Hall","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Sedaghatshoar","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Reyes-Vega","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2980-5393","authenticated-orcid":false,"given":"Harideep","family":"Samanapally","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Raghuram","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"},{"name":"Norton Healthcare, Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Ghare","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish","family":"Barve","sequence":"additional","affiliation":[{"name":"University of Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Aaron E. Blum C. Seidman D. Hoyt M. J. Simone J. Sullivan M. Smith D. K. (2018). Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care STDS 32(1) 16\u201323. https:\/\/doi.org\/10.1089\/apc.2017.0201","DOI":"10.1089\/apc.2017.0201"},{"key":"e_1_3_3_3_1","unstructured":"AIDSVu. (2024). Understanding the current HIV epidemic in Kentucky. https:\/\/map.aidsvu.org\/profiles\/state\/kentucky\/overview"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"Arnold E. A. Hazelton P. Lane T. Christopoulos K. A. Galindo G. R. Steward W. T. Morin S. F. (2012). A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One 7(7) Article e40603. https:\/\/doi.org\/10.1371\/journal.pone.0040603","DOI":"10.1371\/journal.pone.0040603"},{"key":"e_1_3_3_5_1","doi-asserted-by":"crossref","unstructured":"Barata I. A. Shandro J. R. Montgomery M. Polansky R. Sachs C. J. Duber H. C. Weaver L. M. Heins A. Owen H. S. Josephson E. B. Macias-Konstantopoulos W. (2017). Effectiveness of SBIRT for alcohol use disorders in the emergency department: A systematic review.Western Journal of Emergency Medicine 18(6) Article 1143. https:\/\/doi.org\/10.5811\/westjem.2017.7.34373","DOI":"10.5811\/westjem.2017.7.34373"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Babor T. F. McRee B. G. Kassebaum P. A. Grimaldi P. L. Ahmed K. Bray J. (2007). Screening brief intervention and referral to treatment (SBIRT): Toward a public health approach to the management of substance abuse. Alcohol\/Drug Screening and Brief Intervention 28(3) 7\u201330. https:\/\/doi.org\/10.1300\/J465v28n03_03","DOI":"10.1300\/J465v28n03_03"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Birt L. Scott S. Cavers D. Campbell C. Walter F. (2016). Member checking: A tool to enhance trustworthiness or merely a nod to validation? Qualitative Health Research 26(13) 1802\u20131811. https:\/\/doi.org\/10.1177\/1049732316654870","DOI":"10.1177\/1049732316654870"},{"key":"e_1_3_3_8_1","volume-title":"Symbolic interactionism: Perspective and method","author":"Blumer H.","year":"1969","unstructured":"Blumer H. (1969). Symbolic interactionism: Perspective and method. University of California Press."},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Blumenthal J. Pasipanodya E. C. Jain S. Sun S. Ellorin E. Morris S. Moore D. J. (2019). Comparing Self-report pre-exposure prophylaxis adherence questions to pharmacologic measures of recent and cumulative pre-exposure prophylaxis exposure. Frontiers in Pharmacology 10 Article 721. https:\/\/doi.org\/10.3389\/fphar.2019.00721","DOI":"10.3389\/fphar.2019.00721"},{"key":"e_1_3_3_10_1","volume-title":"Sensitizing concepts","author":"Bowen G. A.","year":"2020","unstructured":"Bowen G. A. (2020). Sensitizing concepts. Sage Publications Limited."},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Braun V. Clarke V. (2012). Thematic analysis. In Cooper H. Camic P. M. Long D. L. Panter A. T. Rindskopf D. Sher K. J. (Eds.) APA handbook of research methods in psychology Vol. 2: Research designs: Quantitative qualitative neuropsychological and biological (pp. 57\u201371). American Psychological Association. https:\/\/doi.org\/10.1037\/13620-004","DOI":"10.1037\/13620-004"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Braun V. Clarke V. (2021). To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qualitative Research in Sport Exercise and Health 13(2) 201\u2013216. https:\/\/doi.org\/10.1080\/2159676X.2019.1704846","DOI":"10.1080\/2159676X.2019.1704846"},{"key":"e_1_3_3_13_1","unstructured":"Buchbinder S. P. Liu A. Y. (2019). CROI 2019: Advances in HIV prevention and plans to end the epidemic. Top Antiviral Medicine 27(1) 8\u201325. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31136999"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-020-00533-y"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Calabrese S. K. Rao S. Eldahan A. I. Tekeste M. Modrakovic D. Dangaran D. Boone C. A. Underhill K. Krakower D. S. Mayer K. H. Hansen N. B. Kershaw T. S. Magnus M. Betancourt J. R. Dovidio J. F. (2022). \u201cLet\u2019s be a person to person and have a genuine conversation\u201d: Comparing perspectives on PrEP and sexual health communication between black sexual minority men and healthcare providers. Archives of Sex Behavior 51(5) 2583\u20132601. https:\/\/doi.org\/10.1007\/s10508-021-02213-3","DOI":"10.1007\/s10508-021-02213-3"},{"key":"e_1_3_3_16_1","unstructured":"Centers for Disease Control and Prevention. (2021). Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 update: A clinical practice guideline. https:\/\/stacks.cdc.gov\/view\/cdc\/112360"},{"key":"e_1_3_3_17_1","unstructured":"Centers for Disease Control and Prevention. (2024 April 04). Compendium of evidence based interventions and best practices for HIV prevention: Background methods and criteria. https:\/\/stacks.cdc.gov\/view\/cdc\/149681"},{"key":"e_1_3_3_18_1","volume-title":"Constructing grounded theory","author":"Charmaz K.","year":"2014","unstructured":"Charmaz K. (2014). Constructing grounded theory (2nd ed.). Sage Publications.","edition":"2"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"Dolezal C. Frasca T. Giguere R. Ibitoye M. Cranston R. D. Febo I. Mayer K. H. McGowan I. Carballo-Dieguez A. (2015). Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston Pittsburgh and San Juan. AIDS Eduction and Prevention 27(4) 289\u2013297. https:\/\/doi.org\/10.1521\/aeap.2015.27.4.289","DOI":"10.1521\/aeap.2015.27.4.289"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"Dombrowski J. C. Simoni J. M. Katz D. A. Golden M. R. (2015). Barriers to HIV care and treatment among participants in a public health HIV care relinkage program. AIDS Patient Care and STDS 29(5) 279\u2013287. https:\/\/doi.org\/10.1089\/apc.2014.0346","DOI":"10.1089\/apc.2014.0346"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Dubov A. Galbo P.Jr. Altice F. L. Fraenkel L. (2018). Stigma and shame experiences by MSM who take PrEP for HIV prevention: A qualitative study. American Journal of Men\u2019s Health 12(6) 1843\u20131854. https:\/\/doi.org\/10.1177\/1557988318797437","DOI":"10.1177\/1557988318797437"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Eaton L. A. Driffin D. D. Bauermeister J. Smith H. Conway-Washington C. (2015). Minimal awareness and stalled uptake of pre-exposure prophylaxis (PrEP) among at risk HIV-negative black men who have sex with men. AIDS Patient Care and STDS 29(8) 423\u2013429. https:\/\/doi.org\/10.1089\/apc.2014.0303","DOI":"10.1089\/apc.2014.0303"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Edgman-Levitan S. Schoenbaum S. C. (2021). Patient-centered care: Achieving higher quality by designing care through the patient\u2019s eyes. Israel Journal of Health Policy Research 10(1) Article 21. https:\/\/doi.org\/10.1186\/s13584-021-00459-9","DOI":"10.1186\/s13584-021-00459-9"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","unstructured":"Garett R. Young S. D. (2022). The impact of misinformation and health literacy on HIV prevention and service usage. Journal of the Association of Nurses in AIDS Care 33(1) e1\u2013e5. https:\/\/doi.org\/10.1097\/JNC.0000000000000298","DOI":"10.1097\/JNC.0000000000000298"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Gilead Sciences I. (2025a). Welcome to Gilead Advancing Access\u00ae Program. https:\/\/www.gileadadvancingaccess.com\/?utm_medium%20=%20r%C3%A9f%C3%A9rence","DOI":"10.1109\/MVT.2025.3638086"},{"key":"e_1_3_3_26_1","unstructured":"Gilead Sciences I. (2025b). Yeztugo\u00ae (Lenacapavir) is now the first and only FDA-approved HIV prevention option offering 6 months of protection. https:\/\/www.gilead.com\/news\/news-details\/2025\/yeztugo-lenacapavir-is-now-the-first-and-only-fda-approved-hiv-prevention-option-offering-6-months-of-protection"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","unstructured":"Grov C. Rendina H. J. John S. A. Parsons J. T. (2019). Determining the roles that club drugs marijuana and heavy drinking play in PrEP medication adherence among Gay and Bisexual men: Implications for treatment and research. AIDS and Behavior 23(5) 1277\u20131286. https:\/\/doi.org\/10.1007\/s10461-018-2309-9","DOI":"10.1007\/s10461-018-2309-9"},{"key":"e_1_3_3_28_1","doi-asserted-by":"crossref","unstructured":"Haberer J. E. Mujugira A. Mayer K. H. (2023). The future of HIV pre-exposure prophylaxis adherence: Reducing barriers and increasing opportunities. The Lancet HIV 10(6) e404\u2013e411. https:\/\/doi.org\/10.1016\/S2352-3018(23)00079-6","DOI":"10.1016\/S2352-3018(23)00079-6"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","unstructured":"Hargreaves J. R. Delany-Moretlwe S. Hallett T. B. Johnson S. Kapiga S. Bhattacharjee P. Dallabetta G. Garnett G. P. (2016). The HIV prevention cascade: Integrating theories of epidemiological behavioural and social science into programme design and monitoring. The Lancet HIV 3(7) e318\u2013e322. https:\/\/doi.org\/10.1016\/S2352-3018(16)30063-7","DOI":"10.1016\/S2352-3018(16)30063-7"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","unstructured":"Harris L. M. Skidmore B. D. Nzama N. Al Araydeh M. Kerr J. C. Hall M. T. Reyes-Vega A. Samanapally H. Bkhet A. Ghare S. Barve S. (2025). \u201cTaking charge and being responsible\u201d: A qualitative study of meaning making and motivations for preexposure prophylaxis adherence among gay bisexual and other sexual minoritized men engaged in alcohol misuse in Kentucky. Journal of the Association of Nurses in AIDS Care 36(3) 298\u2013314. https:\/\/doi.org\/10.1097\/JNC.0000000000000541","DOI":"10.1097\/JNC.0000000000000541"},{"key":"e_1_3_3_31_1","doi-asserted-by":"crossref","unstructured":"Hojilla J. C. Marcus J. Volk J. E. Leyden W. Hare C. B. Hechter R. C. Edelman E.J. Silverberg M. Satre D. D. (2020). Alcohol and drug use partner PrEP use and STI prevalence among people with HIV. Sexually Transmitted Infections 96(3) 184\u2013188. https:\/\/doi.org\/10.1136\/sextrans-2019-054049","DOI":"10.1136\/sextrans-2019-054049"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","unstructured":"Hosek S. G. Rudy B. Landovitz R. Kapogiannis B. Siberry G. Rutledge B. Liu N. Brothers J. Mulligan K. Zimet G. Lally M. Mayer K. H. Anderson P. Kiser J. Rooney J. F. Wilson C. M. & Adolescent Trials Network for H. I. (2017). An HIV preexposure prophylaxis demonstration project and safety study for young MSM. Journal of Acquired Immune Deficiency Syndrome 74(1) 21\u201329. https:\/\/doi.org\/10.1097\/QAI.0000000000001179","DOI":"10.1097\/QAI.0000000000001179"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"Jackson K. J. McCoy S. I. White D. A. (2024). A decade of HIV preexposure prophylaxis (PrEP): Overcoming access barriers in the United States through expanded delivery. Public Health Reports\u00ae 139(4) 405\u2013411. https:\/\/doi.org\/10.1177\/00333549231208487","DOI":"10.1177\/00333549231208487"},{"key":"e_1_3_3_34_1","doi-asserted-by":"crossref","unstructured":"Jaramillo J. Maya D. H. Safren S. A. Harkness A. (2025). What makes peers credible? A qualitative analysis to operationalize peer credibility in HIV-prevention and treatment programs for Latino MSM. AIDS Care 37(1) 132\u2013140. https:\/\/doi.org\/10.1080\/09540121.2024.2437078","DOI":"10.1080\/09540121.2024.2437078"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","unstructured":"Keddem S. Thatipelli S. Caceres O. Roder N. Momplaisir F. Cronholm P. (2024). Barriers and facilitators to long-acting injectable HIV pre-exposure prophylaxis implementation in primary care since its approval in the United States. Journal of Acquired Immune Deficiency Syndrome 95(4) 370\u2013376. https:\/\/doi.org\/10.1097\/QAI.0000000000003370","DOI":"10.1097\/QAI.0000000000003370"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","unstructured":"Laborde N. D. Kinley P. M. Spinelli M. Vittinghoff E. Whitacre R. Scott H. M. Buchbinder S. P. (2020). Understanding PrEP persistence: Provider and patient perspectives. AIDS and Behavior 24(9) 2509\u20132519. https:\/\/doi.org\/10.1007\/s10461-020-02807-3","DOI":"10.1007\/s10461-020-02807-3"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0147-1767(85)90062-8"},{"key":"e_1_3_3_38_1","doi-asserted-by":"crossref","unstructured":"Luehring-Jones P. Palfai T. P. Tahaney K. D. Maisto S. A. Simons J. (2019). Pre-exposure prophylaxis (PrEP) use is associated with health risk behaviors among moderate- and heavy-drinking MSM. AIDS Education and Prevention 31(5) 452\u2013462. https:\/\/doi.org\/10.1521\/aeap.2019.31.5.452","DOI":"10.1521\/aeap.2019.31.5.452"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","unstructured":"Marcus J. L. Buisker T. Horvath T. Amico K. R. Fuchs J. D. Buchbinder S. P. Grant R. M. Liu A. Y. (2014). Helping our patients take HIV pre-exposure prophylaxis (PrEP): A systematic review of adherence interventions. HIV Medicine 15(7) 385\u2013395. https:\/\/doi.org\/10.1111\/hiv.12132","DOI":"10.1111\/hiv.12132"},{"key":"e_1_3_3_40_1","doi-asserted-by":"crossref","unstructured":"Mayer K. H. Agwu A. Malebranche D. (2020). Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review. Advances in Therapy 37(5) 1778\u20131811. https:\/\/doi.org\/10.1007\/s12325-020-01295-0","DOI":"10.1007\/s12325-020-01295-0"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","unstructured":"Mayer K. H. Chan P. A. R R. P. Flash C. A. Krakower D. S. (2018). Evolving models and ongoing challenges for HIV preexposure prophylaxis implementation in the United States. Journal of Acquired Immune Deficiency Syndrome 77(2) 119\u2013127. https:\/\/doi.org\/10.1097\/QAI.0000000000001579","DOI":"10.1097\/QAI.0000000000001579"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","unstructured":"Mayer K. H. Krakower D. S. (2015). Editorial commentary: Scaling up antiretroviral preexposure prophylaxis: Moving from trials to implementation. Clincal Infectious Diseases 61(10) 1598\u20131600. https:\/\/doi.org\/10.1093\/cid\/civ665","DOI":"10.1093\/cid\/civ665"},{"key":"e_1_3_3_43_1","unstructured":"National Center for Drug Abuse Statistics. (2023). Alcohol abuse statistics [2023]: National + State Data. https:\/\/drugabusestatistics.org\/alcohol-abuse-statistics\/"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","unstructured":"Norton W. E. Larson R. S. Dearing J. W. (2013). Primary care and public health partnerships for implementing pre-exposure prophylaxis. American Journal of Preventive Medicine 44(1 Suppl 2) S77\u2013S79. https:\/\/doi.org\/10.1016\/j.amepre.2012.09.037","DOI":"10.1016\/j.amepre.2012.09.037"},{"key":"e_1_3_3_45_1","doi-asserted-by":"crossref","unstructured":"Nunn A. S. Brinkley-Rubinstein L. Oldenburg C. E. Mayer K. H. Mimiaga M. Patel R. Chan P. A. (2017). Defining the HIV pre-exposure prophylaxis care continuum. AIDS 31(5) 731\u2013734. https:\/\/doi.org\/10.1097\/QAD.0000000000001385","DOI":"10.1097\/QAD.0000000000001385"},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","unstructured":"Okafor C. N. Hucks-Ortiz C. Hightow-Weidman L. B. Magnus M. Emel L. Beauchamp G. Kuo I. Hendrix C. Mayer K. H. Shoptaw S. J. (2020). Brief report: Associations between self-reported substance use behaviors and PrEP Acceptance and adherence among black MSM in the HPTN 073 study. Journal of Acquired Immune Deficiency Syndrome 85(1) 23\u201329. https:\/\/doi.org\/10.1097\/QAI.0000000000002407","DOI":"10.1097\/QAI.0000000000002407"},{"key":"e_1_3_3_47_1","volume-title":"Qualitative methods in social work research","author":"Padgett D. K.","year":"2016","unstructured":"Padgett D. K. (2016). Qualitative methods in social work research (Vol. 36). Sage publications."},{"key":"#cr-split#-e_1_3_3_48_1.1","doi-asserted-by":"crossref","unstructured":"P\u00e9rula-Jim\u00e9nez C. Romero-Rodr\u00edguez E. Fern\u00e1ndez-Garc\u00eda J. A. Parras-Rejano J. M. Carmona-Casado A. B. Rich-Ruiz M. Gonz\u00e1lez-De la Rubia A. Baleato-Gomez J. & on behalf of the Collaborative Group ALCO-AP20 Study. (2024). Effectiveness of a motivational interviewing-based intervention in decreasing risky alcohol use in primary care patients in Spain: A controlled clinical trial. Healthcare 12","DOI":"10.3390\/healthcare12191970"},{"key":"#cr-split#-e_1_3_3_48_1.2","doi-asserted-by":"crossref","unstructured":"(19) Article 1970. https:\/\/doi.org\/10.3390\/healthcare12191970","DOI":"10.3390\/healthcare12191970"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","unstructured":"Pichon L. C. Teti M. Betts J. E. Brantley M. (2022). \u2018PrEP\u2019ing Memphis: A qualitative process evaluation of peer navigation support. Evaluation and Program Planning 90 Article 101989. https:\/\/doi.org\/10.1016\/j.evalprogplan.2021.101989","DOI":"10.1016\/j.evalprogplan.2021.101989"},{"key":"e_1_3_3_50_1","unstructured":"Picker Institute. (2025). The picker principles of person centred care. https:\/\/picker.org\/who-we-are\/the-picker-principles-of-person-centred-care\/"},{"key":"e_1_3_3_51_1","doi-asserted-by":"crossref","unstructured":"Pleuhs B. Quinn K. G. Walsh J. L. Petroll A. E. John S. A. (2020). Health care provider barriers to HIV pre-exposure prophylaxis in the United States: A systematic review. AIDS Patient Care and STDs 34(3) 111\u2013123. https:\/\/doi.org\/10.1089\/apc.2019.0189","DOI":"10.1089\/apc.2019.0189"},{"key":"e_1_3_3_52_1","doi-asserted-by":"crossref","unstructured":"Rahimi S. (2024). Saturation in qualitative research: An evolutionary concept analysis. International Journal of Nursing Studies Advances 6 Article 100174. https:\/\/doi.org\/10.1016\/j.ijnsa.2024.100174","DOI":"10.1016\/j.ijnsa.2024.100174"},{"key":"e_1_3_3_53_1","doi-asserted-by":"crossref","unstructured":"Rosenstock I. M. (1974). The health belief model and preventive health behavior. Health Education Monographs 2(4) 354\u2013386. https:\/\/doi.org\/10.1177\/109019817400200405","DOI":"10.1177\/109019817400200405"},{"key":"e_1_3_3_54_1","doi-asserted-by":"crossref","unstructured":"Sacks J. J. Gonzales K. R. Bouchery E. E. Tomedi L. E. Brewer R. D. (2015). 2010 National and State costs of excessive alcohol consumption. American Journal of Preventive Medicine 49(5) e73\u2013e79. https:\/\/doi.org\/10.1016\/j.amepre.2015.05.031","DOI":"10.1016\/j.amepre.2015.05.031"},{"key":"e_1_3_3_55_1","doi-asserted-by":"crossref","unstructured":"Sandelowski M. (2010). What\u2019s in a name? Qualitative description revisited. Research in Nursing & Health 33(1) 77\u201384. https:\/\/doi.org\/10.1002\/nur.20362","DOI":"10.1002\/nur.20362"},{"key":"e_1_3_3_56_1","doi-asserted-by":"crossref","unstructured":"Sargent M. Matthews L. J. Yon G. V. Storholm E. D. Ober A. J. Green H. DJr. (2024). Assessing the dynamics of PrEP adoption in a national-scale physician network. Social Networks 78 226\u2013237. https:\/\/doi.org\/10.1016\/j.socnet.2024.02.001","DOI":"10.1016\/j.socnet.2024.02.001"},{"key":"e_1_3_3_57_1","doi-asserted-by":"crossref","unstructured":"Saunders J. B. Aasland O. G. Babor T. F. de la Fuente J. R. Grant M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2013II. Addiction 88(6) 791\u2013804. https:\/\/doi.org\/10.1111\/j.1360-0443.1993.tb02093.x","DOI":"10.1111\/j.1360-0443.1993.tb02093.x"},{"key":"e_1_3_3_58_1","doi-asserted-by":"crossref","unstructured":"Sewell W. C. Solleveld P. Seidman D. Dehlendorf C. Marcus J. L. Krakower D. S. (2021). Patient-led decision-making for HIV preexposure prophylaxis. Current HIV\/AIDS Reports 18(1) 48\u201356. https:\/\/doi.org\/10.1007\/s11904-020-00535-w","DOI":"10.1007\/s11904-020-00535-w"},{"key":"#cr-split#-e_1_3_3_59_1.1","doi-asserted-by":"crossref","unstructured":"Shuper P. A. Joharchi N. Bogoch II Loutfy M. Crouzat F. El-Helou P. Knox D. C. Woodward K. Rehm J. (2020). Alcohol consumption substance use and depression in relation to HIV pre-exposure prophylaxis (PrEP) nonadherence among gay bisexual and other men-who-have-sex-with-men. BMC Public Health 20","DOI":"10.1186\/s12889-020-09883-z"},{"key":"#cr-split#-e_1_3_3_59_1.2","doi-asserted-by":"crossref","unstructured":"(1) Article 1782. https:\/\/doi.org\/10.1186\/s12889-020-09883-z","DOI":"10.1186\/s12889-020-09883-z"},{"key":"e_1_3_3_60_1","doi-asserted-by":"crossref","unstructured":"Siegler A. J. Mouhanna F. Giler R. M. Weiss K. Pembleton E. Guest J. Jones J. Castel A. Yeung H. Kramer M. McCallister S. Sullivan P. S. (2018). The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017 United States. Annals Epidemiology 28(12) 841\u2013849. https:\/\/doi.org\/10.1016\/j.annepidem.2018.06.005","DOI":"10.1016\/j.annepidem.2018.06.005"},{"key":"e_1_3_3_61_1","volume-title":"Dedoose Version 9.0","author":"SocioCultural Research Consultants, L","year":"2024","unstructured":"SocioCultural Research Consultants, L. (2024). Dedoose Version 9.0. SocioCultural Research Consultants."},{"key":"e_1_3_3_62_1","doi-asserted-by":"crossref","unstructured":"Srikanth K. Killelea A. Strumpf A. Corbin-Gutierrez E. Horn T. McManus K. A. (2022). Associated costs are a barrier to HIV preexposure prophylaxis access in the United States. American Journal of Public Health Association 112(6) 834\u2013838. https:\/\/doi.org\/10.2105\/AJPH.2022.306793","DOI":"10.2105\/AJPH.2022.306793"},{"key":"e_1_3_3_63_1","doi-asserted-by":"crossref","unstructured":"Storholm E. D. Volk J. E. Marcus J. L. Silverberg M. J. Satre D. D. (2017). Risk perception sexual behaviors and PrEP adherence among substance-using men who have sex with men: A qualitative study. Prevention Science 18 737\u2013747.https:\/\/doi.org\/10.1007\/s11121-017-0799-8","DOI":"10.1007\/s11121-017-0799-8"},{"key":"e_1_3_3_64_1","doi-asserted-by":"crossref","unstructured":"Strong S. H. Oldfield B. J. van den Berg J. J. Cole C. A. Biegacki E. Ogbuagu O. Virata M. Chan P. A. Edelman E. J. (2024). Perspectives on unhealthy alcohol use among men who have sex with men prescribed HIV pre-exposure prophylaxis: A qualitative study. Preventive Medicine Reports 37 Article 102553. https:\/\/doi.org\/10.1016\/j.pmedr.2023.102553","DOI":"10.1016\/j.pmedr.2023.102553"},{"key":"e_1_3_3_65_1","doi-asserted-by":"crossref","unstructured":"Sullivan P. S. DuBose S. N. Castel A. D. Hoover K. W. Juhasz M. Guest J. L. Le G. Whitby S. Siegler A. J. (2024). Equity of PrEP uptake by race ethnicity sex and region in the United States in the first decade of PrEP: A population-based analysis. The Lancet Regional Health Americas 33 Article 100738. https:\/\/doi.org\/10.1016\/j.lana.2024.100738","DOI":"10.1016\/j.lana.2024.100738"},{"key":"e_1_3_3_66_1","doi-asserted-by":"crossref","unstructured":"Sullivan P. S. Mena L. Elopre L. Siegler A. J. (2019). Implementation Strategies to Increase PrEP Uptake in the South. Current HIV\/AIDS Reports 16(4) 259\u2013269. https:\/\/doi.org\/10.1007\/s11904-019-00447-4","DOI":"10.1007\/s11904-019-00447-4"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.4324\/9781003503538"},{"key":"e_1_3_3_68_1","unstructured":"U.S. Food & Drug Administration. (2021). FDA approves first injectable treatment for HIV pre-exposure prevention. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention"},{"key":"e_1_3_3_69_1","volume-title":"Prevention of acquisition of HIV\u201d preexposure prophylaxis","author":"U.S. Preventive Services Task Force","year":"2023","unstructured":"U.S. Preventive Services Task Force. (2023). Prevention of acquisition of HIV\u201d preexposure prophylaxis. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis"},{"key":"e_1_3_3_70_1","doi-asserted-by":"crossref","unstructured":"Wang H. Delnoij M. Zimmermann H. M. Jonas K. J. (2025). The disparities of PrEP adherence among men who have sex with men between the Global South and the Global North: An updated determinantal global meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes 99(1) 1\u20138. https:\/\/doi.org\/10.1097\/QAI.0000000000003635","DOI":"10.1097\/QAI.0000000000003635"},{"key":"e_1_3_3_71_1","doi-asserted-by":"crossref","unstructured":"Watson R. J. Morgan E. Collibee C. Kalinowski J. Cunningham C. Edelman E. J. Chan P. Eaton L. A. (2022). Substance use and healthcare utilization across the pre-exposure prophylaxis (PrEP) care cascade among black and Latino men who have sex with men. Substance Use & Misuse 57(11) 1698\u20131707. https:\/\/doi.org\/10.1080\/10826084.2022.2108059","DOI":"10.1080\/10826084.2022.2108059"},{"key":"e_1_3_3_72_1","doi-asserted-by":"crossref","unstructured":"Zhang J. Li C. Xu J. Hu Z. Rutstein S. E. Tucker J. D. Ong J. J. Jiang Y. Geng W. Wright S. T. Cohen M. S. Shang H. Tang W. (2022). Discontinuation suboptimal adherence and reinitiation of oral HIV pre-exposure prophylaxis: A global systematic review and meta-analysis. The Lancet HIV 9(4) e254\u2013e268. https:\/\/doi.org\/10.1016\/S2352-3018(22)00030-3","DOI":"10.1016\/S2352-3018(22)00030-3"}],"container-title":["Global Qualitative Nursing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23333936261429417","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23333936261429417","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23333936261429417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:13:29Z","timestamp":1777446809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23333936261429417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":73,"alternative-id":["10.1177\/23333936261429417"],"URL":"https:\/\/doi.org\/10.1177\/23333936261429417","relation":{},"ISSN":["2333-3936","2333-3936"],"issn-type":[{"value":"2333-3936","type":"print"},{"value":"2333-3936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"article-number":"23333936261429417"}}